Hunan Qianshan Pharmaceutical Machinery Co., Ltd. (hereinafter referred to as "the Company") received the Shenzhen Stock Exchange's decision on the termination of its stock listing on July 14, 2020.
Important Notice:
- Type of stock to be delisted: RMB ordinary shares
- Stock abbreviation: Qianshan Pharmaceutical Machinery
- Stock code: 300216
- Delisting date: July 14, 2020
On July 14, 2020, the Shenzhen Stock Exchange decided to terminate the listing of the Company's stock due to the negative net assets attributable to shareholders of the listed company as of the end of 2018. The financial reports for 2017 and 2018 received audit reports from registered accountants expressing an inability to issue an opinion. The Company's stock has been suspended from listing since May 13, 2019.
As of June 30, 2020, the Company's disclosed 2019 annual report indicated that the net profit attributable to shareholders of the listed company, net profit after deducting non-recurring gains and losses, and net assets were all negative, and the financial report received an audit report from Liananda Accounting Firm (Special General Partnership) expressing an inability to issue an opinion, triggering the delisting conditions specified in Article 13.4.1 of the Shenzhen Stock Exchange's "Listing Rules for Growth Enterprise Market Stocks (Revised November 2018)."